• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在抗凝治疗期间发生复发性静脉血栓栓塞症。

Recurrent venous thromboembolism while on anticoagulant therapy.

机构信息

Department of Haematology, Roald Dahl Haemostasis and Thrombosis Centre, Royal Liverpool University Hospital, Liverpool L7 8XP, United Kingdom.

出版信息

Blood Rev. 2012 Jul;26(4):175-81. doi: 10.1016/j.blre.2012.04.002. Epub 2012 May 2.

DOI:10.1016/j.blre.2012.04.002
PMID:22560652
Abstract

There has been immense progress in the management of venous thromboembolism in recent years with increased awareness and adequate thromboprophylaxis proving successful in reducing the morbidity and mortality associated with this condition. One of the commonest complications of an initial venous thrombosis is the development of recurrent thrombosis. Unlike in the case of the first clot, the diagnosis and management of the recurrent episode remain a difficult issue. Even more challenging is the clinical situation where a new thrombus develops while the patient is being treated with anticoagulant medication for a previous clot. The clinical approach and management of these patients are complex, and require understanding of the differences in thrombus development in the different clinical circumstances.

摘要

近年来,静脉血栓栓塞症的管理取得了巨大进展,通过提高认识和充分的血栓预防,成功降低了与该疾病相关的发病率和死亡率。初始静脉血栓形成的最常见并发症之一是复发性血栓形成。与首次血栓形成不同,复发性血栓形成的诊断和管理仍然是一个难题。更具挑战性的是,在患者因前一次血栓形成而接受抗凝药物治疗的情况下,新的血栓形成。这些患者的临床处理和管理很复杂,需要了解不同临床情况下血栓形成的差异。

相似文献

1
Recurrent venous thromboembolism while on anticoagulant therapy.在抗凝治疗期间发生复发性静脉血栓栓塞症。
Blood Rev. 2012 Jul;26(4):175-81. doi: 10.1016/j.blre.2012.04.002. Epub 2012 May 2.
2
Perioperative anticoagulant management.围手术期抗凝管理。
Med Clin North Am. 2009 Sep;93(5):1105-21. doi: 10.1016/j.mcna.2009.05.002.
3
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.首次发作特发性静脉血栓栓塞症时三个月抗凝治疗与长期抗凝治疗的比较。
N Engl J Med. 1999 Mar 25;340(12):901-7. doi: 10.1056/NEJM199903253401201.
4
Duration of anticoagulant therapy for patients with venous thromboembolism.静脉血栓栓塞症患者的抗凝治疗持续时间。
Thromb Res. 2008;123 Suppl 1:S62-4. doi: 10.1016/j.thromres.2008.08.019. Epub 2008 Sep 26.
5
Long-term anticoagulation for venous thromboembolism: duration of treatment and management of warfarin therapy.静脉血栓栓塞症的长期抗凝治疗:治疗持续时间和华法林治疗管理。
Clin Chest Med. 2010 Dec;31(4):719-30. doi: 10.1016/j.ccm.2010.06.003.
6
Unprovoked venous thromboembolism: Short term or indefinite anticoagulation? Balancing long-term risk and benefit.特发性静脉血栓栓塞症:短期抗凝还是无限期抗凝?权衡长期风险和获益。
Blood Rev. 2010 Jul-Sep;24(4-5):171-8. doi: 10.1016/j.blre.2010.06.001. Epub 2010 Jul 14.
7
Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.肝素和低分子量肝素治疗静脉血栓栓塞症。抗凝监测的黄昏。
Int Angiol. 1998 Dec;17(4):213-24.
8
Unanswered questions in venous thromboembolism.静脉血栓栓塞症中的未解决问题。
Thromb Res. 2009;123 Suppl 4:S2-S10. doi: 10.1016/S0049-3848(09)70135-5.
9
Long-term anticoagulation treatment for acute venous thromboembolism in patients with and without cancer. The SWIss Venous ThromboEmbolism Registry (SWIVTER) II.癌症患者与非癌症患者急性静脉血栓栓塞的长期抗凝治疗。瑞士静脉血栓栓塞注册研究(SWIVTER) II 期。
Thromb Haemost. 2011 Jun;105(6):962-7. doi: 10.1160/TH11-01-0002. Epub 2011 Apr 7.
10
Venous thromboembolism in pregnancy.妊娠期静脉血栓栓塞症。
Clin Chest Med. 2010 Dec;31(4):731-40. doi: 10.1016/j.ccm.2010.06.004.

引用本文的文献

1
Lessons Learned From a Case of Behcet's Disease Presenting With Fever and Life-Threatening Venous Thromboembolism.从一例以发热和危及生命的静脉血栓栓塞为表现的白塞病病例中吸取的教训
Cureus. 2022 Dec 15;14(12):e32546. doi: 10.7759/cureus.32546. eCollection 2022 Dec.
2
Advanced delivery strategies facilitating oral absorption of heparins.促进肝素口服吸收的先进给药策略。
Asian J Pharm Sci. 2020 Jul;15(4):449-460. doi: 10.1016/j.ajps.2019.11.006. Epub 2020 Jan 9.
3
Antibodies Against Complement Components: Relevance for the Antiphospholipid Syndrome-Biomarkers of the Disease and Biopharmaceuticals.
抗补体成分抗体:与抗磷脂综合征的相关性——疾病生物标志物与生物制药
Curr Rheumatol Rep. 2017 Jul;19(7):40. doi: 10.1007/s11926-017-0669-1.
4
Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism.华法林治疗静脉血栓栓塞症的实际管理指南。
J Thromb Thrombolysis. 2016 Jan;41(1):187-205. doi: 10.1007/s11239-015-1319-y.
5
Providing accurate information to patients who develop deep vein thrombosis.为发生深静脉血栓的患者提供准确信息。
Clin Med (Lond). 2013 Oct;13(5):449-51. doi: 10.7861/clinmedicine.13-5-449.